黑色素瘤免疫疗法:进展,陷和未来的前景
Cristina Sorino1, Simona Iezzi1, Ludovica Ciuffreda1
1SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
Frontiers in molecular biosciences
|August 1, 2024
概括
免疫疗法彻底改变了黑色素瘤的治疗方法,但耐药性和副作用等挑战仍然存在. 了解瘤微环境是提高黑色素瘤免疫疗法的有效性和开发新生物标志物的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤黑色素瘤是一种具有高转移潜力的侵袭性皮肤癌.
- 向疗法和免疫疗法改善了黑色素瘤患者的治疗结果.
- 目前的治疗方法由于副作用和抵抗机制而面临局限性.
研究的目的:
- 审查当前针对黑色素瘤的免疫治疗策略.
- 分析瘤微环境在免疫治疗反应中的作用.
- 确定在黑色素瘤治疗和生物标志物发现方面需要改进的领域.
主要方法:
- 对当前黑色素瘤免疫治疗策略的文献综述.
- 分析瘤微环境与免疫系统之间的相互作用.
- 检查黑色素瘤免疫逃避机制.
主要成果:
- 免疫疗法和向疗法显著改善了黑色素瘤的生存率和生活质量.
- 瘤微环境极大地影响免疫治疗的反应和疗效.
- 黑色素瘤细胞使用各种机制来逃避免疫.
结论:
- 进一步了解瘤微环境相互作用对于提高黑色素瘤免疫疗法至关重要.
- 识别预测生物标志物对于优化治疗选择至关重要.
- 需要改进治疗策略,以克服耐药性并减少黑色素瘤管理中的副作用.
相关概念视频
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


